Carlsmed (NasdaqGS:CARL) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsCaroline Corner - Investor RelationsFelipe Lamar - Senior Equity Research AssociateLeo Greenstein - CFOMichael Cordonnier - CEO and ChairmanTravis Steed - Managing Director in Equity ResearchConference Call ParticipantsJenny Rabinowitz - Global Investment Research AnalystRyan Zimmerman - Managing Director and Senior Equity Research AnalystNone - AnalystOperatorLadies and gentlemen, thank you for standing by, and ...

Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion ...